ST. LOUIS, Aug. 27, 2015 /PRNewswire/
-- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading
Life Science and Technology Company, today announced it has signed
an agreement with Public Health England (PHE) to manufacture and
supply bacterial and fungal NCTC/NCPF Certified Reference Materials
(CRM) in LENTICULE® disc format worldwide for use as
controls in food, water, environmental and clinical testing
microbiology laboratories.
"Sigma-Aldrich is excited to offer the global scientific
community access to the LENTICULE disc portfolio," said
Trevor Jones, Vice President for the
Sigma-Aldrich Analytical Business. "The addition of these certified
reference materials supports our aim to offer a broad portfolio of
products that accelerate customers' confidence in the quality and
accuracy of analytical data."
Each CRM LENTICULE disc consists of a stipulated level of a pure
culture of viable bacteria or fungi in a control-dried
water-soluble matrix. The bacterial and fungal strains are prepared
directly from strains selected from PHE's National Collection of
Type Cultures (NCTC) and National Collection of Pathogenic Fungi
(NCPF).
"Our agreement with Sigma-Aldrich will enable more scientists
worldwide to easily access the NCTC/NCPF CRMs," said Julie Russell, Head of PHE's Culture
Collections. "Licensing the LENTICULE disc technology to
Sigma-Aldrich means the PHE microbiologists can concentrate on the
development of new products to improve health outcomes, while end
users benefit from Sigma-Aldrich's expertise in manufacturing and
global distribution."
The CRMs will be produced in accordance with ISO Guide 34 and
individually packed at Sigma-Aldrich for customer convenience. "We
have invested in a new, dedicated Biosafety Level 2 facility and
expanded the scope of our ISO 17025/ ISO Guide 34 accreditation to
manufacture this product range in full accordance with our
Environmental Health and Safety (EHS) and quality guidelines," said
Fabian Wahl, Ph.D., Business
Development Director at Sigma-Aldrich.
For more information on Sigma-Aldrich's NCTC/NCPF CRMs in
LENTICULE disc format, visit www.sigma.com/lenticules.
Cautionary Statement: The foregoing release contains
forward-looking statements that can be identified by terminology
such as "will enable," "will be produced" or similar expressions,
or by expressed or implied discussions regarding potential future
revenues from products derived there from. You should not place
undue reliance on these statements. Such forward-looking statements
reflect the current views of management regarding future events,
and involve known and unknown risks, uncertainties and other
factors that may cause actual results to be materially different
from any future results, performance or achievements expressed or
implied by such statements. There can be no guarantee that this or
any other license agreement will assist the Company to achieve any
particular levels of revenue in the future. In particular,
management's expectations regarding this license agreement could be
affected by, among other things, the Company's ability to obtain or
maintain patent or other proprietary intellectual property
protection; competition in general; government, industry and
general public pricing pressures; the impact that the foregoing
factors could have on the values attributed to the Company's assets
and liabilities as recorded in its consolidated balance sheet, and
other risks and factors referred to in Sigma-Aldrich's current Form
10-K on file with the US Securities and Exchange Commission. Should
one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those anticipated, believed, estimated or expected.
Sigma-Aldrich is providing the
information in this press release as of this date and does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich, a
leading Life Science and Technology company focused on enhancing
human health and safety, manufactures and distributes 250,000
chemicals, biochemicals and other essential products to more than
1.4 million customers globally in research and applied labs as well
as in industrial and commercial markets. With three distinct
business units - Research, Applied and SAFC Commercial -
Sigma-Aldrich is committed to enabling science to improve the
quality of life. The Company operates in 37 countries, has 9,700
employees worldwide and had sales of $2.79
billion in 2014. For more information about Sigma-Aldrich,
please visit its website at www.sigma-aldrich.com.
Sigma-Aldrich and Sigma are
trademarks of Sigma-Aldrich Co, LLC registered in the US and other
countries. LENTICULE is a trademark of The Secretary of State for
Health, registered in the UK, the US and other countries.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sigma-aldrich-announces-agreement-with-public-health-england-to-manufacture-and-supply-nctcncpf-certified-reference-materials-300133718.html
SOURCE Sigma-Aldrich Corporation